back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-03-20 Tx date 2018-03-17 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
| Filed 2017-09-05 Tx date 2017-08-31 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,000
+50,000 vol $1.60 each |
50,000 | |
| Filed 2017-09-05 Tx date 2015-07-14 |
$ACST
Acasti Pharma Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-24 Tx date 2017-08-17 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,051
+36,082 vol $1.11 each |
57,061 | |
| Filed 2016-07-28 Tx date 2016-07-26 |
$NTB
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$29,999
+20,979 vol $1.43 each |
20,979 | |
| Filed 2016-07-28 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-23 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-23 Tx date 2015-07-14 |
$APO
Acasti Pharma Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-20 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-20 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Crewe, Katherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,000
+75,000 vol $1.72 each |
75,000 |